Last Updated:

Bishak Pharma Private Limited loan details

Charges taken from banks & financial institutes

Data last updated:

Amount in (₹)

Bishak Pharma Private Limited has 8 charges registered with the Registrar of Companies: 7 open charges worth Rs 40.64 Cr and 1 satisfied charge worth Rs 5.00 Cr. The lender named on its open charges is Axis Bank Limited. The most recent charge was created on 14 Aug 2025 for Rs 37.50 Cr and is open.

Charges Breakdown by Lending Institutions

  • Others : 39.40 Cr
  • Axis Bank Limited : 1.24 Cr

₹40.64 crore

₹5.00 crore

3

Others

Modification

20 Aug 2025

₹37.50 cr

Charge IdLenderAmountCreation DateLast Modification DateSatisfaction DateStatus
10354932 View DetailsThe Karur Vysya Bank Limited₹ 5.00 28 Apr 2012-01 Jan 2019 Satisfied 50000000.0
101144811 View DetailsOthers₹ 37.50 14 Aug 202520 Aug 2025- Open 375000000.0
100845601 View DetailsOthers₹ 1.00 28 Dec 2023-- Open 10000000.0
100660219 View DetailsOthers₹ 0.30 10 Oct 2022-- Open 3000000.0
100648184 View DetailsOthers₹ 0.30 10 Oct 2022-- Open 3000000.0
100647894 View DetailsOthers₹ 0.30 10 Oct 2022-- Open 3000000.0
100569748 View DetailsAxis Bank Limited₹ 0.31 07 Mar 2022-- Open 3100000.0
100569728 View DetailsAxis Bank Limited₹ 0.93 11 Feb 2022-- Open 9300000.0
Premium access

Charge documents and asset details

The filed charge documents and the assets pledged under each charge are in the company report.

  • Assets and property pledged under each charge
  • Terms and conditions as filed
  • Filed charge documents where available

Verified entity values are shown only after access is granted.

A charge is a security interest a company creates over its assets in favour of a lender. An open charge is still outstanding; a satisfied charge has been repaid and closed with the Registrar. Under the Companies Act, 2013 every charge must be registered within thirty days of creation (Form CHG-1, or CHG-9 for debentures) and its satisfaction reported within thirty days of repayment (Form CHG-4). Amounts are as filed with the MCA.